1Mitophagy in acute central nervous system injuries:regulatory mechanisms and therapeutic potentialsSiyi Xu, Junqiu Jia, Rui Mao, Xiang Cao, Yun Xu2437-24532Targeting harmful effects of non-excitatory amino acids as an alternative therapeutic strategy to reduce ischemic damageVictoria Jiménez Carretero, Iris Álvarez-Merz, Jorge Hernández-Campano, Sergei A.Kirov, Jesús M.Hernández-Guijo2454-24633Crosstalk among canonical Wnt and Hippo pathway members in skeletal muscle and at the neuromuscular junctionSaid Hashemolhosseini, Lea Gessler2464-24794Olfactory receptors in neural regeneration in the central nervous systemRafael Franco, Claudia Garrigós, Toni Capó, Joan Serrano-Marín, Rafael Rivas-Santisteban, Jaume Lillo2480-24945The dopaminergic system and Alzheimer's diseaseYuhan Zhang, Yuan Liang, Yixue Gu2495-25126Acquired sensorineural hearing loss,oxidative stress,and microRNAsDesmond A.Nunez, Ru C.Guo2513-25197Glucocorticoid receptor signaling in the brain and its involvement in cognitive functionChonglin Su, Taiqi Huang, Meiyu Zhang, Yanyu Zhang, Yan Zeng, Xingxing Chen2520-25378Nanocarrier-mediated siRNA delivery:a new approach for the treatment of traumatic brain injury-related Alzheimer's diseaseJie Jin, Huajing Zhang, Qianying Lu, Linqiang Tian, Sanqiao Yao, Feng Lai, Yangfan Liang, Chuanchuan Liu, Yujia Lu, Sijia Tian, Yanmei Zhao, Wenjie Ren2538-25559Blood diagnostic and prognostic biomarkers in amyotrophic lateral sclerosisYongting Lv, Hongfu Li2556-257010Spinal cord injury regenerative therapy development:integration of design of experimentsYuji Okano, Hideyuki Okano, Yoshitaka Kase2571-257311Many faces of neuronal activity manipulation in DrosophilaAmber Krebs, Steffen Kautzmann, Christian Klämbt2574-257612Apolipoprotein E elicits target-directed miRNA degradation to maintain neuronal integrityJiazi Tan, Chin-Tong Ong2577-257813Cellular models of stress resistance may pave ways to fight neurodegenerative diseasesThu Nguyen Minh Pham, Christian Behl2579-258014Crosstalk between androgen signaling and the chemokine receptor CXCR4:a novel strategy to promote myelin regenerationMarianne Bardy-Lagarde, Narimène Asbelaoui, Abdel Mouman Ghoumari2581-258215Translational challenges in amyotrophic lateral sclerosis therapy with macrophage migration inhibitory factorLeenor Alfahel, Aleksandar Rajkovic, Adrian Israelson2583-258416Soluble epoxide hydrolase:a next-generation drug target for Alzheimer's disease and related dementiasAndrew Gregory, Chengyun Tang, Fan Fan2585-258617Tale of mitochondria and mitochondria-associated ER membrane in patient-derived neuronal models of Wolfram syndromeLaetitia Aubry, Timothy Barrett, Sovan Sarkar2587-258818Disruption of neuronal actin barrier promotes the entry of disease-implicated proteins to exacerbate amyotrophic lateral sclerosis pathologyMikio Shimizu, Tatsusada Okuno2589-259019Emerging potential of progranulin-dependent SorCS2 signaling in healthy and diseased nervous systemsAlena Salasova, Anders Nykjær2591-259320Syndecans in Alzheimer's disease:pathogenetic mechanisms and potential therapeutic targetsCarmela Rita Balistreri, Roberto Monastero2594-2595 